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Trypanosoma brucei expresses variant surface
glycoprotein (VSG) genes in a strictly monoallelic
fashion in its mammalian hosts, but it is unclear
how this important virulence mechanism is enforced.
Telomere position effect, an epigenetic phenom-
enon, has been proposed to play a critical role in
VSG regulation, yet no telomeric protein has been
identified whose disruption led to VSG derepression.
We now identify tbRAP1 as an intrinsic component of
the T. brucei telomere complex and amajor regulator
for silencing VSG expression sites (ESs). Knockdown
of tbRAP1 led to derepression of all VSGs in silent
ESs, but not VSGs located elsewhere, and resulted
in stronger derepression of genes located within
10 kb from telomeres than genes located further
upstream. This graduated silencing pattern suggests
that telomere integrity plays a key role in tbRAP1-
dependent silencing and VSG regulation.
INTRODUCTION
Trypanosoma brucei is a unicellular protozoan parasite that
causes human African trypanosomiasis. In the bloodstream of
its mammalian host, T. brucei periodically switches the major
component of its surface coat, the variant surface glycoprotein
(VSG; Barry and McCulloch, 2001), thereby evading immune
elimination. Although there are more than 1000 VSG genes and
pseudogenes in the T. brucei genome (Berriman et al., 2005;
Marcello and Barry, 2007), VSGs can only be expressed from 1
of 20 (Navarro and Cross, 1996) nearly identical VSG expres-
sion sites (ESs; Barry and McCulloch, 2001; Hertz-Fowler
et al., 2008), which are polycistronically transcribed byRNApoly-
merase I (Pol I; Gunzl et al., 2003) and are located immediately
upstream of telomeres (de Lange and Borst, 1982). In most
ESs, theVSG is 0.2–1.6kbupstreamof the telomereDNArepeats,whereas the promoter is 40–60 kb upstream. Promoter-less VSG
genes are also found on minichromosomes within 5 kb of telo-
meres, or on megabase chromosomes in gene clusters located
at subtelomeric regions (Horn and Barry, 2005).
Mechanisms that ensure the monoallelic VSG expression
remain elusive, even though several hypotheses have been
proposed (Pays et al., 2004). One study showed that ‘‘silent’’
ES promoters are actually moderately active, but that transcrip-
tion is rapidly attenuated, suggesting that transcription elonga-
tion is regulated (Vanhamme et al., 2000). Another study showed
that only the active ES colocalizes with Pol I at an extranucleolar
site, dubbed the expression site body (ESB; Navarro and Gull,
2001; Landeira and Navarro, 2007), suggesting that recruitment
or limitation of a single ES to the ESB is crucial. Recent studies
showed that depletion of a T. brucei homolog of the chromatin
remodeling factor ISWI (TbISWI) elevated silent ES promoter
activities without affecting VSG transcription (Hughes et al.,
2007), and deletion of tbDot1B, a histone H3 methyltransferase,
led to a 10-fold increase in silent VSG transcripts (Figueiredo
et al., 2008), suggesting that chromatin modifications are impor-
tant for ES silencing. Finally, because VSG is exclusively
expressed from subtelomeric loci (de Lange and Borst, 1982),
it has been proposed that the telomere structure plays an impor-
tant role in VSG expression regulation (Horn and Cross, 1995;
Horn and Barry, 2005; Glover and Horn, 2006; Dreesen et al.,
2007).
Telomere-specific proteins are indispensable for telomere
functions, which include protection of chromosome ends and
maintenance of telomere lengths and the specialized telomere
chromatin structure. Much is known about the mammalian telo-
mere complex, which contains six core proteins (de Lange,
2005). Among these, TRF2 binds duplex telomere DNA and
maintains chromosome end integrity. So far, tbTRF, a functional
homolog of TRF2, is the only known T. brucei telomere-specific
protein (Li et al., 2005). Another mammalian telomeric protein is
RAP1, which does not contact DNA but is recruited to telomeres
through its interaction with TRF2 (Li et al., 2000). In contrast,
S. cerevisiae RAP1 is the predominant duplex telomere-DNA-
binding factor (Shore, 1994). The difference between the DNACell 137, 99–109, April 3, 2009 ª2009 Elsevier Inc. 99
binding activities of hRAP1 and scRAP1 can be explained by the
fact that scRAP1 has myb and myb-like domains for DNA recog-
nition whereas hRAP1 has a single myb domain with a negative
surface charge on its third helix (Konig and Rhodes, 1997;
Hanaoka et al., 2001).
ScRAP1 is essential for the telomeric heterochromatic struc-
ture, which can repress the transcription of subtelomeric genes,
an epigenetic phenomenon termed telomere position effect
(TPE; Gottschling et al., 1990). For genes targeted to subtelo-
meric loci, TPE is typically stronger at telomere-proximal than
telomere-distal regions, spreading continuously inwards from
telomeres (Renauld et al., 1993). However, TPE at native chro-
mosome ends can be discontinuous, with a peak of repression
at subtelomeric regions not immediately adjacent to telomeres
(Pryde and Louis, 1999). TPE has also been observed in T. brucei
and mammalian cells when reporter genes are analyzed (Glover
et al., 2007; Glover and Horn, 2006; Gao et al., 2007; Pedram
et al., 2006).
Many other proteins are involved in TPE, including the NAD+-
dependent histone deacetylases scSir2 and mammalian SIRT6
(Gasser and Cockell, 2001; Michishita et al., 2008), and yeast
Ku70/80, which binds DNA ends (Mishra and Shore, 1999; Evans
et al., 1998; Boulton and Jackson, 1998). The T. brucei Sir2
homolog, SIR2rp1, is also important for TPE (Alsford et al.,
2007). Interestingly, the P. falciparum Sir2 homolog is essential
for the telomeric heterochromatic structure and necessary for
the monoallelic expression of subtelomeric var genes, which
are critical virulence genes involved in antigenic variation (Frei-
tas-Junior et al., 2005; Duraisingh et al., 2005). In T. brucei,
however, there is no direct evidence supporting the idea that
telomeres are important for monoallelic VSG expression. Deple-
tion of tbTRF, telomerase, SIR2rp1, or tbKu80 had no effect on
VSG expression (Li et al., 2005; Alsford et al., 2007; Glover
et al., 2007; Janzen et al., 2004; Conway et al., 2002).
In this study, we report the identification of a novel T. brucei te-
lomeric protein, tbRAP1, which interacts with tbTRF, associates
with telomere DNA, and is essential for silencing ES-associated
VSGs.
RESULTS
Identification of tbRAP1 as a tbTRF-Interacting Factor
We previously identified tbTRF as a telomeric protein that is
essential for the telomere terminal structure but not VSG expres-
sion (Li et al., 2005). To identify additional telomere components,
we carried out a yeast two-hybrid screen using tbTRF as bait.
More than ten tbTRF-interacting candidates were identified,
including the conserved hypothetical protein Tb11.03.0760.
This protein has an N-terminal BRCA1 C-terminus (BRCT)
domain (Figures 1A and 1B), which is present in many proteins
involved in DNA damage repair or cell-cycle checkpoints (Bork
et al., 1997). Because RAP1 is the only known telomeric protein
with an N-terminal BRCT domain (Li et al., 2000; Kanoh and Ish-
ikawa, 2001; Park et al., 2002; Callebaut and Mornon, 1997), we
compared this protein with known RAP1s more carefully. Clus-
talW analysis showed that this protein also has two central
regions very similar to the myb and myb-like domains in scRAP1
(Figure 1), so we named this protein tbRAP1.100 Cell 137, 99–109, April 3, 2009 ª2009 Elsevier Inc.The sequence identity between tbRAP1 BRCT and other RAP1
BRCTs is 8%–18% (ClustalW), with the putative b1 b sheet being
the most conserved region (Figure 1B; Zhang et al., 1998). The
sequence homology is stronger within the myb and the myb-like
domains, with identities of 18%–22% and 10%–23%, respec-
tively (Figures1Cand1D). Interestingly, both tbRAP1andspRAP1
lack the C-terminal RCT protein-protein interaction domain
(Figure 1A; Li et al., 2000), suggesting that tbRAP1uses a different
motif to interact with other proteins. Indeed, the N-terminal two
thirds of tbRAP1 (amino acids 2–653) is sufficient and necessary
for the interaction with tbTRF (Figure 2A). Compared with tbTRF
self-interaction, the affinity of tbRAP1 to tbTRF is lower
(Figure 2A). This is similar to the interaction between hRAP1 and
hTRF2, which is weaker than hTRF2 self-interaction in a yeast
two-hybrid assay (Broccoli et al., 1997; Li et al., 2000).
To confirm that tbRAP1 interacts with tbTRF in vivo, we carried
out coimmunoprecipitation (coIP) using a rabbit antibody against
tbTRF or a monoclonal antibody against the HA epitope tag, in
cells containing a FLAG-HA-HA (F2H)-tagged tbRAP1 at its
endogenous locus. In several independent experiments, we
observed 3%–14% of F2H-tbRAP1 coIP with the endogenous
tbTRF and nearly 10% of tbTRF coIP with the F2H-tbRAP1
(Figure 2B), confirming that tbRAP1 interacts with tbTRF
in vivo, though weakly.
To confirm that tbRAP1 is a telomeric protein, we examined its
subnuclear localization. Three T. brucei cell lines in which an
endogenous tbRAP1 was tagged with an N-terminal Ty1, GFP,
or F2H epitope were established. Indirect immunofluorescence
(IF) was carried out with anti-tag monoclonal antibodies and an
anti-tbTRF rabbit antibody. All the Ty1-, GFP-, and F2H-tagged
tbRAP1 proteins partially colocalized with the endogenous
tbTRF (Figure 2C; data not shown), which was confirmed by
using an anti-tbRAP1 rabbit antibody (data not shown). These
data suggest that tbRAP1 is localized at telomeres and possibly
in other subnuclear compartments. This is similar to scRAP1,
which targets 5% of the promoters in the yeast genome, in addi-
tion to telomere DNA (Pina et al., 2003).
To further confirm that tbRAP1associateswith the telomere,we
carried out chromatin immunoprecipitation (ChIP) using a rabbit
antibody against tbRAP1. We observed that telomere DNA was
enriched in tbRAP1 and tbTRF ChIP (Figure 2D). In contrast,
control DNAs, including the tubulin gene array and a random
single-copy gene Tb11.0330, were not enriched in tbRAP1 or
tbTRF ChIP under the same conditions, nor was telomere DNA
enriched in any ChIP without formaldehyde crosslinking. TbTRF
antibody precipitated more telomere DNA than tbRAP1 in normal
ChIP (Figure 2D), which is consistent with the observation that all
tbTRF but not all tbRAP1 seems to reside at telomeres.
TbRAP1 Is Essential for Normal Cell Growth
TbRAP1 double-allele knockout cell lines could not be estab-
lishedeven thoughcells havingone tbRAP1alleledeletedshowed
no growth defect (data not shown), suggesting that tbRAP1 is
essential for cell growth. We therefore established inducible
tbRAP1 RNAi cell lines: Ri-2 in VSG2-expressing SM cells (Wirtz
et al., 1999) and Ri-9 in VSG9-expressing PVS3-2/OD1-1 cells
(derived fromSM cells). Both cell lines have a Ty1-tagged endog-
enous tbRAP1 allele and constitutively express the T7 RNA
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Figure 1. TbRAP1 Is Homologous to Telomeric RAP1 Proteins
(A) Domain structures for hRAP1, scRAP1, spRAP1, and tbRAP1. BRCT, myb, myb-like, and RCT (RAP1 C-terminal) domains are marked.
(B) Sequence alignment for RAP1 BRCT domains. The putative a helices and b sheets are marked as a1–3 and b1–4, respectively (Bork et al., 1997; Zhang et al.,
1998). c1 and c2 are linker regions.
(C) Sequence alignment for RAP1 myb domains. The three putative helices are marked as cylinders above or below the sequences.
(D) Sequence alignment for RAP1 myb-like domains.
For (B)–(D), amino acids positions are indicated. Sequence similarities (Kyte and Doolittle, 1982) are shaded. Identical residues are boxed. ca, Candida albicans;
gg,Gallus gallus; h, human; kl,Kluyveromyces lactis; m,mouse; sc,Saccharomyces cerevisiae; sp,Schizosaccharomyces pombe; su,Saccharomyces unisporus;
tb, Trypanosoma brucei; xl, Xenopus laevis; zr, Zygosaccharomyces rouxii.polymerase and the tet repressor. Ri-2 and Ri-9 are therefore
isogenic but express different VSGs. After inducing tbRAP1
RNAi, western analysis showed that Ty1-tbRAP1 was greatly
diminished by 12 hr and was undetectable by 36 hr (Figure 3A),
indicating that knockdown of tbRAP1 was effective. Growth ofthese cells was arrested by 48 hr after induction (Figure 3B),
confirming that tbRAP1 is essential for normal cell growth.
We next examined whether depletion of tbRAP1 led to any
telomere defect. To avoid nonspecific effects, tbRAP1 RNAi
was induced for no more than 3 days, and three populationCell 137, 99–109, April 3, 2009 ª2009 Elsevier Inc. 101
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Figure 2. TbRAP1 Is a Telomeric Protein
(A) TbRAP1 interacts with tbTRF in yeast two-hybrid analysis. LexA binding domain (LexABD)-fused tbTRF and various Gal4 activation domain (GAD)-fused
tbRAP1 fragments were used. Their interactions are shown as the average and standard deviation of b-galactosidase activities calculated from at least three
independent assays. Positive results are highlighted in red.
(B) The endogenous F2H-tbRAP1 partially coIP with the endogenous tbTRF. In the left panel, an anti-tbTRF antibody 1260 (Li et al., 2005) was used for IP, and
anti-HA monoclonal antibody 12CA5 was used for western blotting (WB). In the right panel, 12CA5 was used for IP and a chicken antibody against tbTRF was
used for western blotting. Input (10%), sup (supernatant, 10%), and pellet (IP product, 30%) were indicated.
(C) Ty1-tbRAP1 partially colocalizes with tbTRF. Cells with an endogenous Ty1-tbRAP1 were stained with a rabbit antibody against endogenous tbTRF (green)
(Li et al., 2005) and a monoclonal antibody (BB2) against Ty1 (red). DAPI was used to stain DNA (blue).
(D) Endogenous tbRAP1 associates with telomere DNA. ChIP was carried out either with (+X) or without (X) formaldehyde cross-linking, using rabbit antibody
against tbRAP1 or tbTRF, or, as a control, with no antibody. The average amounts of precipitated TTAGGG-repeat, tubulin, and Tb11.0330 DNA were calculated
from three to seven experiments. Standard deviations are shown as error bars. Unpaired t tests were done to compare results from ChIP using tbRAP1 or tbTRF
antibody with those using no antibody, and the resulting p values are listed over corresponding columns.doublings (PDs) passed before growth was arrested. Telomere
lengths were compared before and after the RNAi induction by
Southern blotting, but no obvious telomere length changes
were observed (data not shown).
TbRAP1 Is Essential for Silencing ES VSGs
Because scRAP1 is well known for its essential role in TPE (Grun-
stein, 1997), we examined the possibility that tbRAP1 might play
a role in VSG regulation.
The T. brucei Lister 427 strain contains 14 different VSGs in 15
ESs (Hertz-Fowler et al., 2008). We examined the expression of
all 14 VSGs using quantitative real-time polymerase chain reac-
tion (RT-PCR). To avoid effects from differences in mRNA
stability and PCR efficiency, we compared mRNA levels for indi-
vidual VSGs before and after induction of tbRAP1 RNAi.
In two independent Ri-2 lines (Table 1), all VSG mRNA levels
(except VSG2) were increased 2- to 25-fold or 8- to 56-fold after
18 or 36 hr of tbRAP1 RNAi induction, respectively. At both time102 Cell 137, 99–109, April 3, 2009 ª2009 Elsevier Inc.points, Ty1-tbRAP1 levels dropped to less than 6% of wild-type
levels (Figure 3A). In contrast, VSG2 expression exhibited
a subtle decrease, and rRNA levels were stable (Tables 1 and
2). In addition to Pol I-transcribed VSGs and rRNA, we examined
RNA polymerase II (Pol II)-transcribed tbTRF, tbTERT, and
histone H4 (tbHH4), and found no more than 2-fold changes in
their mRNA levels (Table 2). Because scRAP1 is also known to
activate the expression of ribosomal protein and glycolytic
protein genes (Pina et al., 2003), we also examined tbRPS15
(Tb927.7.2370), a putative ribosomal protein gene, and tbPGI
(Tb927.1.3830), which encodes glycosomal glucose-6-phos-
phate isomerase. There was no more than a 3-fold increase in
the corresponding mRNA levels (Table 2), indicating that tbRAP1
is not necessary for their transcription. Finally, in parental cells
lacking the tbRAP1 RNAi construct, the mRNA level for all tested
genes exhibited less than 3-fold variation (Tables 1 and 2).
To determine whether VSG-derepression was specific to
VSG2-expressors, we examined mRNA levels of various VSGs
in the VSG9-expressing Ri-9 cell line. Northern analysis showed
the same derepression for all tested VSGs, including VSGs 2, 3,
11, 13, 15, 17, 18, and 21 (Figure S1 available online). Therefore,
the VSG-derepression induced by tbRAP1 knockdown is not
specific to cells expressing a particular VSG. No VSG derepres-
sion was detected in tbTRF RNAi and control cells with empty
RNAi vector (Figure S1A).
To determine whether a derepressed VSG in tbRAP1 depleted
cells was transcribed at a similar level as when it is in an active
ES, we used quantitative RT-PCR to compare the mRNA level
of derepressed VSG2 in Ri-9 cells to that of VSG2 in Ri-2 cells.
In Ri-9 cells, upon tbRAP1 knockdown, even when VSG2 was
maximally derepressed (100-fold), its mRNA was still 70- to
100-fold less abundant than that in Ri-2 cells. Similarly, when
a luciferase gene was located immediately downstream of an
ES promoter, it had an activity of 3000–4000 units when the ES
was active, but only 1–2 units when the ES was silent (after an
in situ ES switch), and a maximum of 40 units when the ES
was subsequently derepressed upon tbRAP1 knockdown.
Therefore, the derepressed ESs were transcribed at an interme-
diate level between silent and fully active. This also means that in
a silent ES, promoter-proximal and telomere-proximal genes are
transcribed at 0.3% and 0.01% of their fully active levels,
respectively.
Table 1. Depletion of tbRAP1 Resulted in Derepression of All Known ES VSGsa
Cells hr VSG2 VSG3 VSG6 VSG8 VSG9 VSG11 VSG13 VSG14 VSG15 VSG16 VSG17 VSG18 VSG19 VSG21
Ri-2(1) 0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
18 0.5/0.1 5.8/1.2 16.3/0.3 6.6/0.7 8.4/0.1 25.4/6.4 9.0/0.7 2.1/0.4 12.6/1.0 9.1/5.2 12.8/3.4 7.1/2.4 2.4/0.2 6.1/0.5
24 0.5/0.1 7.1/2.8 22.7/13.4 8.4/2.8 10.9/3.5 29.8/1.9 11.9/5.6 1.9/0.1 12.4/0.2 9.7/6.1 14.1/4.0 5.4/1.7 14.5/7.4 9.5/2.0
36 0.7/0.6 7.8/0.3 19.7/5.5 9.0/1.0 14.5/2.0 40.6/1.0 8.0/1.1 8.9/0.0 43.9/1.3 36.9/30.5 17.7/1.2 15.9/0.1 N/A 13.1/1.3
Ri-2(2) 0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
18 0.5/0.1 2.6/0.9 11.2/1.3 3.1/0.9 3.3/0.8 12.6/6.0 4.6/1.6 2.4/0.0 11.3/2.5 9.4/2.5 5.9/3.3 3.9/0.5 2.6/1.0 4.1/1.1
24 0.5/0.1 6.5/2.2 40.3/35.2 8.9/0.8 9.4/3.8 23.4/7.3 8.3/2.3 2.8/0.2 16.4/0.3 9.1/4.8 24.4/13.9 5.2/1.7 5.5/0.9 8.7/0.2
36 0.7/0.6 9.5/1.9 55.5/46.4 16.2/7.8 19.5/11.6 45.2/19.7 11.8/0.2 12.5/0.3 52.6/2.9 34.7/30.1 37.3/7.7 23.1/11.9 23.1/9.2 19.4/9.5
Parent 0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
18 1.1/0.5 1.8/0.1 1.6/0.8 1.2/0.2 0.7/0.1 1.6/0.1 1.1/0.4 1.1/0.2 1.2/0.2 1.4/1.2 1.0/0.3 0.7/0.3 N/A 1.4/0.2
24 0.5/0.1 1.0/0.5 1.7/0.8 0.9/0.2 0.6/0.3 1.3/0.3 0.9/0.0 0.9/0.1 1.1/0.1 1.2/0.8 0.9/0.2 0.5/0.2 2.8/0.3 1.4/0.1
36 1.0/0.6 2.8/1.3 1.8/1.2 1.2/0.3 1.0/0.3 2.2/0.1 1.3/0.4 1.2/0.0 0.9/0.1 1.8/1.1 1.2/0.5 0.6/0.1 1.3/0.3 1.5/0.6
a In both tables, the fold of increase in mRNA levels is shown as average/standard deviation calculated from quantitative real-time RT-PCR results
using RNA samples collected at indicated time points from 3–7 independent inductions.
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Figure 3. TbRAP1 Is Essential for Normal Cell Growth
(A) Induction of tbRAP1 RNAi resulted in efficient decrease in cellular tbRAP1
protein level. Whole cell lysates were prepared from Ri-2, clone 2 (top) or Ri-9,
clone 3 cells (bottom). BB2 anti-Ty1 antibody was used for western blotting.
Tubulin is shown as a loading control in this and following figures.
(B) Knockdown of tbRAP1 led to growth arrest. Growth curves were generated
from five independent inductions. Average PDs against time are shown for two
independent Ri-9 cell lines and their parent with (+) or without () doxycycline
induction (Dox). Standard deviations are shown as error bars. A similar result
was observed in Ri-2 cells (data not shown).
Table 2. Depletion of tbRAP1 Does Not Affect Various Control
Genes
Cells hr rRNA tbTRF tbTERT tbHH4 tbRPS15 tbPGI
Ri-2(1) 0 1.0 N/A N/A N/A 1.0 1.0
18 1.3/0.2 N/A N/A N/A 1.2/0.9 1.0/0.3
24 1.3/0.3 N/A N/A N/A 1.1/0.5 1.8/0.7
36 1.2/0.4 N/A N/A N/A 3.0/2.0 2.2/0.7
Ri-2(2) 0 1.0 1.0 1.0 1.0 N/A N/A
18 1.1/0.2 1.4/0.3 1.1/0.4 0.8/0.1 N/A N/A
24 1.2/0.2 1.7/0.9 1.4/0.7 1.2/0.7 N/A N/A
36 1.3/0.7 2.3/1.1 2.0/1.0 2.3/1.0 N/A N/A
Parent 0 1.0 1.0 1.0 1.0 1.0 1.0
18 0.8/0.2 1.1/0.3 1.1/0.4 0.8/0.1 0.5/0.3 0.8/0.7
24 0.7/0.3 1.1/0.2 0.8/0.3 0.9/0.1 0.4/0.3 0.8/0.3
36 0.7/0.1 0.8/0.4 0.6/0.3 1.0/0.1 0.9/0.6 1.1/0.2Cell 137, 99–109, April 3, 2009 ª2009 Elsevier Inc. 103
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Figure 4. TbRAP1 Knockdown Resulted in Derepression of VSGs in Silent ESs and an Increase in the Number of Extranucleolar Pol I Foci
(A and B) Western analysis of derepressed VSGs. Whole cell lysates were prepared from Ri-2 clone 2 (A) or Ri-9 clone 3 (B) cells at various times after induction
and probed with purified antibodies specific for VSG2, VSG13, or VSG9. The signal intensities of different VSGs are not comparable due to different affinities of
various antibodies.
(C) IF analyses in Ri-9 clone 3 cells at indicated times after induction of tbRAP1 RNAi. Purified chicken antibodies specific for VSG2 (green) and rabbit antibody
specific for VSG13 (red) were used. DNA was stained with DAPI (blue).
(D) TbRAP1 depletion led to a mild increase in the number of extranucleolar Pol I foci. The number of Pol I foci was determined by staining cells with Pol I antibody
(red) (Navarro and Gull, 2001). Nucleoli were identified as regions that stain less with DAPI. Representative nuclei with 0, 1, or more extranucleolar Pol I foci are
shown at the bottom. The percent of cells among a population falling into each category were scored in three independent experiments and the average and
standard deviation (error bars) are indicated. Total number of examined nuclei is indicated next to the legend. P values are shown as results of unpaired t tests
between induced or noninduced samples.To test whether VSG derepression requires a promoter, we
analyzed the expression of two promoter-less single-copy
VSGs in both Ri-2 and Ri-9 cells. VSG5 is at a nontelomeric locus
(Horn and Cross, 1997), whereas VSGG4 is at a subtelomeric
locus on a minichromosome (Alsford et al., 2001; data not
shown). Although primers for these two VSGs generated specific
PCRproducts, their expression levels were not higher than back-
ground either before or after tbRAP1 knockdown (data not
shown), and no VSG5 or VSGG4 mRNA could be detected in
Ri-9 cells (Figure S1A). Therefore, tbRAP1 is only necessary for
silencing ES-linkedVSGsbut notVSGs elsewhere in the genome.
TbRAP1 Deficiency Led to Simultaneous Expression
of Different VSGs at the Surface of Individual Cells
To determine whether proteins were synthesized from dere-
pressed VSG genes, we carried out western analysis using104 Cell 137, 99–109, April 3, 2009 ª2009 Elsevier Inc.specific antibodies against VSGs 2, 9, and 13. In Ri-2 cells, low
levels of VSG9 and VSG13 were detectable by 12 hr after induc-
tion whereas VSG2 was constantly expressed (Figure 4A). Simi-
larly, in Ri-9 cells, VSG2 and VSG13 were detectable at 6 hr and
18 hr, respectively, whereas the expression of VSG9 remained
constant (Figure 4B). In contrast, none of the silent VSG proteins
were detectable in respective parent, TRF RNAi, or vector
control cells (data not shown).
To determine whether multiple VSGs are expressed simulta-
neously in individual cells, we carried out IF analysis. In Ri-9 cells,
the derepressed VSG2 and VSG13 were detected simulta-
neously on the cell surface (Figure 4C). Using other combinations
of VSG-specific antibodies, we confirmed that VSG9 was
constantly synthesized, and that the derepressed VSG2 and
VSG13 were present in the same VSG9-expressing cells (data
not shown). Although it was impractical for us to test whether
more than two VSGs were actually being synthesized simulta-
neously in individual cells, it is likely that they are.
Wild-type cells have a single active ES, which associates with
the only one Pol I-enriched ESB (Navarro and Gull, 2001).
Because multiple ESs are derepressed upon tbRAP1 depletion,
we examined whether the subnuclear localization of Pol I is
affected in Ri-2 cells by IF analysis using an anti-Pol I monoclonal
antibody (Navarro and Gull, 2001). We observed that the fraction
of cells with more than one extranucleolar Pol I foci increased
from 20% to 50% after tbRAP1 RNAi was induced for 36 hr
(Figure 4D). Interestingly, some of these foci seem to be much
brighter than others, suggesting that different foci contain
unequal amounts of Pol I.
To confirm that VSG derepression was specifically due to
tbRAP1 depletion, we introduced an ectopic inducible F2H-
tagged tbRAP1 into Ri-2 cells. Adding doxycycline to these cells
led to a decrease in Ty1-tbRAP1 and an increase in F2H-tbRAP1
protein level but no detectable VSG9 or VSG13 (Figure S2) or any
change in cell growth, indicating that the VSG-derepression
phenotype resulted specifically from tbRAP1 deficiency.
Although tbTRF is not essential for VSG silencing (Li et al.,
2005), it is possible that tbRAP1 depletion-induced VSG-dere-
pression requires tbTRF function. To test this possibility, we es-
tablished VSG2-expressing cell lines in which tbTRF and tbRAP1
could be knocked down simultaneously. Upon RNAi induction,
VSG9 and VSG13 were still derepressed (Figure S3), indicating
that tbTRF is not required for VSG derepression.
Depletion of VSG in T. brucei results in a cell-cycle arrest at the
precytokinesis stage (Sheader et al., 2005). We questioned
whether expression of multiple VSGs leads to a similar cell-cycle
arrest. Cell-cycle analysis by fluorescence-activated cell sorting
(FACS) showed that the fraction of cells in S phase is significantly
reduced whereas the fraction in G2/M increased mildly after
tbRAP1 depletion (Table S2). Therefore, tbRAP1 deficiency led
to an altered cell-cycle profile that is different from what was
observed in VSG-depleted cells.
TbRAP1 Knockdown Resulted in Greater Derepression
of Genes Closer to Telomeres
TbRAP1 knockdown led to derepression of ES-linked silent
VSGs, and the fold of increase in VSG mRNA should reflect the
strength of tbRAP1-dependent silencing. In all ESs, VSG genes
are located 0.2–1.6 kb from telomeres (Hertz-Fowler et al.,
2008). As tbRAP1 is a telomeric protein, it is possible that
tbRAP1-dependent silencing is stronger closer to telomeres.
To determine how telomere-proximal and telomere-distal genes
were affected after tbRAP1 depletion, we used quantitative
RT-PCR to compare the derepression of unique genes in ES1
that are located at 60 kb (PUR, puromycin resistance), 7 kb
(JES1, a VSG pseudogene), and 1 kb (VSG2) upstream of the
telomere (Figure 5A; Hertz-Fowler et al., 2008). Because inde-
pendent inductions can give substantial variations, we used
the same RNA samples for all three genes in each RT-PCR reac-
tion and present individual experiment results. We found that
PUR is always derepressed by a lesser amount (because, being
close to the promoter, it is already somewhat transcribed in silent
ES) than JES1 and VSG2, although JES1 was derepressed at
a higher level than VSG2 (Figure 5A). Our data indicate thattbRAP1 can silence the whole ES and more strongly closer to
telomeres, albeit the silencing level might fluctuate at regions
immediately upstream of the telomere. The graduated silencing
pattern was confirmed by a similar analysis in ES11, which is
silent in both Ri-2 and Ri-9 cells and has a uniqueJES11 (another
VSG pseudogene) and VSG16 located at 20 kb and 0.5 kb
upstream of the telomere, respectively (Figure 5B; Hertz-Fowler
et al., 2008). In both cell lines, JES11 was derepressed at lower
levels than VSG16 (Figure 5B), indicating that tbRAP1-depen-
dent silencing is stronger at telomere-proximal regions.
DISCUSSION
TbRAP1 as an Intrinsic Component of the T. brucei
Telomere Complex
Our data from yeast two-hybrid, coIP, IF, and ChIP showed that
tbRAP1 interacts with tbTRF and associates with telomeres,
though not exclusively, indicating that tbRAP1, like scRAP1, is
a telomeric protein but also locates elsewhere in the genome
A
B
Figure 5. TbRAP1 Deficiency Led to a Stronger Derepression of
Genes Located Closer to Telomeres
(A) A schematic diagram of the silent ES1 (top, not to scale) and the derepres-
sion levels of PUR, JES1, and VSG2 (bottom) after the tbRAP1 RNAi was
induced for 24 hr in Ri-9 cells. The box with stripes represents the 70 bp
repeats. Numbers indicate ESAG genes.
(B) A schematic diagram of the silent ES11 (top, not to scale) and the derepres-
sion levels of JES11 and VSG16 (bottom) after tbRAP1 RNAi was induced for
36 hr in Ri-2 and Ri-9 cells. In both (A) and (B), the fold of increase in mRNA
level for each gene was measured as described in Table 1. Results from
several independent experiments were shown for Ri-2 and Ri-9 cells. The
results for parental cells are shown as average and standard deviation calcu-
lated from at least three independent experiments.Cell 137, 99–109, April 3, 2009 ª2009 Elsevier Inc. 105
(Pina et al., 2003). No drastic telomere length changes were
observed within three PDs when tbRAP1 RNAi was induced for
3 days, suggesting that tbRAP1 does not suppress rapid telo-
mere length changes that have been observed in yeast, human,
and T. brucei (Li and Lustig, 1996; Wang et al., 2004; van der
Ploeg et al., 1984). However, we cannot exclude the possibility
that tbRAP1participates in telomere lengthcontrol, because telo-
mere lengthchangesdue to telomeraseactivity or the lackof it are
very slow inT. brucei (3–6bp/PD; vanderPloeg et al., 1984;Dree-
sen et al., 2005). A small change in three PDs (expected to be
9–18 bp), if there was any, would not be discernable in Southern
analyses, when the average telomere sizes are 10 kb.
The BRCT and myb domains are ubiquitous among RAP1
homologs (Teixeira and Gilson, 2005), but the function of RAP1
BRCT domain is unknown. The myb and the myb-like domains,
at least in scRAP1, are required for DNA binding (Konig et al.,
1996), as normally a minimum of two myb domains is necessary
for DNA recognition (Ogata et al., 1994). Because tbRAP1 also
contains a myb and a myb-like domain, it might bind telomere
DNA directly. In addition, at least 13% of thymidines in T. brucei
telomere TTAGGG repeats are replaced by the glucosylated
base J in the bloodstream stage (Gommers-Ampt et al., 1991;
van Leeuwen et al., 1996), so it will be interesting to determine
whether tbRAP1 recognizes J-containing telomeres.
Regulation of Telomeric VSG Expression by tbRAP1
To our knowledge, tbRAP1 is the first telomeric protein identified
in T. bruceiwhose depletion led to disruption of monoallelic VSG
expression. All ES-linked VSGs were derepressed upon tbRAP1
knockdown, and this effect was not specific to cells expressing
a particular VSG, suggesting that tbRAP1 is a critical ES tran-
scription suppressor. It is possible that the VSG-silencing func-
tion of tbRAP1 might be independent of the telomere structure,
because tbRAP1 is not exclusively at the telomere and the lack
of obvious telomere length changes within a short period after
tbRAP1 depletion. However, depletion of tbRAP1 did not affect
the transcription of any tested Pol I- or Pol II-transcribed control
genes or non-ES VSGs, indicating that tbRAP1 is not a general
transcription regulator. In addition, tbRAP1-mediated silencing
is stronger in regions within 10 kb of the telomere than those
further upstream, suggesting that telomere structure is essential
for this silencing.
The graduated strength of tbRAP1-dependent silencing is
different in ES11 and ES1, indicating that silencing in different
ESs are not identical. Similar differences have been observed
in yeast, where TPE for subtelomeric reporter genes spreads
continuously inwards from the telomere (Renauld et al., 1993),
whereas TPE at native telomeres can have a peak of silencing
not immediately upstream of the telomere (Pryde and Louis,
1999). In addition, different VSGs are derepessed at various
levels upon tbRAP1 knockdown, which appears independent
of VSG copy numbers or the distance between VSG and the
ES promoter but reflects different levels of silencing in different
ESs. Genome structure and chromosome context presumably
can influence the degree of silencing. Further investigations will
be necessary to determine which ES elements are influential.
In wild-type cells, silent ESs are transcribed at a low level for
a short distance (Vanhamme et al., 2000), suggesting that the106 Cell 137, 99–109, April 3, 2009 ª2009 Elsevier Inc.transcription elongation encounters an increasing antagonizing
effect when it moves toward the telomere. TbRAP1 knockdown
did not affect the active VSG but led to graduated derepression
for genes along a silent ES, suggesting that tbRAP1-dependent
silencing antagonizes transcription elongation from ES
promoters (Figure 6A). Depletion of tbRAP1 lifted the silencing
and the entire ESs including VSGs were transcribed (Figure 6B).
However, derepressed ESs are transcribed at a 70- to 100-fold
lower level than when they are fully active. Hence we propose
that additional mechanisms are necessary to boost an ES to full
activation (Figure 6C). This hypothesis is consistent with the
observation that depletion of the chromatin remodeler tbISWI
led to a partial promoter-proximal ES derepression (Hughes
et al., 2007). Comparing silencing strength of ES-linked with
that of non-ES reporter genes also suggested that a TPE-inde-
pendent but ES-specific silencing is involved in VSG regulation,
further supporting our hypothesis (Glover and Horn, 2006).
It has been proposed that concentrating a limiting amount of
cellular Pol I transcription machinery at the ESB is an important
mechanism to ensure monoallelic VSG expression (Navarro
and Gull, 2001) and that, therefore, two forced fully active ESs
have to switch back and forth rapidly and locate next to each
other in the nucleus (Chaves et al., 1999). We observed an
increase in the number of extranucleolar Pol I foci after tbRAP1
A
B
C
Figure 6. A Model for ES Silencing
ESs are similarly illustrated as in Figure 5. ES transcription is shown as a light
gray bar. TbRAP1-dependent silencing is shown as a dark gray triangle, which
is stronger at telomere-proximal regions.
(A) In wild-type cells, basal level transcription is initiated at silent ES promoters,
but transcription elongation is quickly attenuated when transcription
machinery moves toward the telomere and encounters an increasing level of
tbRAP1-dependent silencing. The net result is a basal level transcription at
the 50 of silent ESs.
(B) When tbRAP1-dependent silencing is removed, transcription initiated at
silent ES promoters can elongate throughout the ES and VSGs are transcribed
at the basal level, which is maximally 100-fold higher than silent but still 70- to
100-fold lower than full activation.
(C) TbRAP1-independent mechanisms are necessary to fully activate an ES.
depletion, suggesting that a small amount of Pol I is available for
multiple ES transcription at basal level.
Conclusions
Telomeres have been proposed to be involved in VSG regulation
ever since the discovery that VSGs are expressed from subtelo-
meric loci (de Lange and Borst, 1982). Recent studies confirmed
that TPE exists in T. brucei but also suggested that telomeres
might not be essential for VSG silencing (Horn and Cross,
1995, 1997; Glover et al., 2007; Glover and Horn, 2006). We
have identified tbRAP1 as a telomeric protein and showed that
it is essential for complete ES VSG silencing. Our data strongly
support the hypothesis that telomeres are important for the regu-
lation of VSG expression.
In budding yeast, TPE depends on scRAP1, which binds to
telomere DNA and recruits Sir proteins to establish a heterochro-
matic structure at telomeres (Grunstein, 1997). Recent studies
indicated that silencing of subtelomeric VSG genes also
depends on specific modifications of the chromatin structure
(Figueiredo et al., 2008; Hughes et al., 2007). However, tbRAP1,
but not SIR2rp1 or tbKu80, is essential for VSG silencing, indi-
cating that tbRAP1-mediated silencing is not exactly the same
as TPE in yeast. In addition, TPE in S. cerevisiae was studied
using genes transcribed by Pol II (Gottschling et al., 1990),
whereas in T. brucei, VSGs are transcribed by Pol I (Gunzl
et al., 2003). It is possible that the chromatin structure affects
transcription by different polymerases in different ways. Further-
more, in budding yeast, TPE affects initiation of gene transcrip-
tion, where a promoter is immediately upstream of the reporter
gene, whereas tbRAP1-mediated silencing seems to affect tran-
scription elongation from ES promoters, which are 40–60 kb
upstream of VSGs. These observations suggest that not all
RAP1 homologs have identical functions and that further studies
of tbRAP1 will be required to identify its precise roles in regu-
lating VSG expression.
EXPERIMENTAL PROCEDURES
Plasmids
The full-length tbRAP1 was PCR amplified from T. brucei TREU927 genomic
DNA and inserted into pLEW82-BSD (Li et al., 2005) together with an
N-terminal F2H tag to generate an inducible tbRAP1 expression construct.
The same fragment was inserted into p2T7-TABlue (Alsford et al., 2005) to
make an inducible tbRAP1 RNAi construct. The subcloned full-length tbRAP1
was sequenced and the result submitted to GenBank (accession FJ597175).
The hygromycin-resistance gene or PUR flanked by tbRAP1 50 and 30 untrans-
lated region (UTR) were inserted into pBluescript SKII+ to make two tbRAP1
deletion constructs. The phleomycin resistance gene, an a/b tubulin intergenic
sequence, and the Ty1 tag (Bastin et al., 1996), together with flanking tbRAP1
50 UTR and the N-terminal 500 bp of tbRAP1, were inserted into pBluescript
SKII+ to generate the tbRAP1 endogenous Ty1 tagging construct. F2H and
GFP tagging constructs were similarly generated except PUR was used.
Various fragments of tbRAP1 open reading frame were PCR amplified from
T. brucei TREU927 genomic DNA and inserted into pACT2 (Clontech) or
pBTM116 to make yeast two-hybrid constructs. The luciferase gene plus
flanking 30 and 50 UTR were excised from pNS11 (Siegel et al., 2005) and
inserted into pLF12 (Figueiredo et al., 2008) to generate pPUR-LUC.
Yeast Two-Hybrid Screen
The pBTM116-tbTRF-FL plasmid (Li et al., 2005) was transformed into yeast
L40 strain (Vojtek et al., 1993), in which the expression of lacZ and HIS3 aredriven by minimal GAL1 and HIS3 promoters fused to multimerized LexA
binding sites. L40 cells harboring LexABD-tbTRF alone gave a mild transcrip-
tion of HIS3, which was suppressed by 2.5 mM 3-aminotriazole. A GAD cDNA
library generated with T. brucei 427 cDNA (Hoek et al., 2002) was used for the
two-hybrid screen. A total of 1.6 million primary transformants were screened
for HIS3 and lacZ expression. GAD-fusion plasmids recovered from positive
transformants were analyzed by restriction digestion. Independent clones
were further tested to confirm that they do not give a positive result by them-
selves and that they interact with LexABD-tbTRF. Clones that passed all
screens were sequenced and the insert identities were determined by search-
ing the T. brucei genome database (Berriman et al., 2005). The interactions
between different fragments of tbTRF and tbRAP1 were analyzed by liquid
assays using ONPG as substrate.
T. brucei Cell Lines
The VSG9 Expressor Cells
The pPUR-LUC plasmid was transfected into VSG2 (also known as VSG221)-
expressing SM cells (Wirtz et al., 1999) to generate Puromycin-resistant clones
PUR-LUC1 (PL1). VSG9-expressing PVS3-2 cells were obtained by injecting
PL1 cells into naive Charles River Strain CD-1 mice followed by isolation of
in situ VSG switchers (confirmed by Southern blotting). To prevent further
in situ switches in culture, the blasticidin-resistance gene was targeted imme-
diately downstream of VSG9 ES promoter to give rise to PVS3-2/OD1-1 cells,
and these cells were maintained with 5 mg/ml blasticidin S.
Inducible tbRAP1 RNAi Cell Lines
Ri-2 cells were obtained by transfecting SM/Ty1-tbRAP1 cells with p2T7-
TABlue-tbRAP1. Ri-9 cells were obtained by transfecting PVS3-2/OD1-1 cells
with p2T7-TABlue-tbRAP1 and tbRAP1 Ty1-tagging constructs. All indepen-
dent tbRAP1 RNAi clones behaved similarly upon induction with 0.1 mg/ml
doxycycline.
Antibodies
Rabbit anti-VSG13, rabbit and chicken anti-VSG2 and the preparation of
cross-reacting-determinant (CRD)-depleted sera were described in Figueir-
edo et al. (2008). Rabbit anti-VSG9 was kindly provided by Piet Borst, and
CRD-depleted antibody was similarly prepared. Chicken antibody 606 was
raised against a His6-tbTRF expressed in bacteria. IgY proteins were first puri-
fied from egg yolks using EggStract kit (Promega) then affinity purified with
His6-tbTRF coupled CNBr-activated beads (GE). Rabbit antibody 597 was
raised against a GST-tbRAP1414-855 expressed from bacteria and purified
with His6-tbRAP1414-855 coupled CNBr-activated beads.
Coimmunoprecipitation
A total of 200 million cells harboring an endogenous F2H-tagged tbRAP1 were
lysed with two rounds of nitrogen cavitation in lysis buffer (50 mM TrisdCl [pH
7.4]; 60 mM KCl, 1.5 mM MgCl2, 0.4 M NaCl, 1 mM EDTA, 0.1% Triton X-
100, 0.01% SDS, 1 mM DTT). Protein extract was dialyzed against dialysis
buffer (20 mM HEPESdKOH [pH 7.9], 0.2 mM EDTA, 0.2 mM EGTA, 100 mM
KCl) and precleared with incubation with protein G beads (Sigma) prewashed
with 1 3 PBS/1% bovine serum albumin. The precleared lysate was used for
IP using either 2 mg 12CA5 against HA (Rockefeller-Memorial Sloan Kettering
Cancer Center Monoclonal AB facility) or 2 ml 1260 against tbTRF (Li et al.,
2005). IP product was washed sequentially with buffer A (0.1%SDS; 1% Triton
X-100; 2mMEDTApH 8.0; 20mMTrisdHCl [pH 8.0]; 150mMNaCl), B (same as
buffer A but with 500 mMNaCl), C (0.25 M LiCl; 1% NP-40; 1% Na-deoxycho-
late; 1 mM EDTA pH 8.0; 10 mM TrisdHCl [pH 8.0]), and TE. All buffers are sup-
plemented with 1 mM PMSF, protease inhibitor cocktail for mammalian cells
(Sigma), 4 mg/ml pepstatin A, and 0.5 mg/ml TLCK immediately before use.
Reverse Transcription and Quantitative RT-PCR
Total RNAwas extracted from cells using RNAstat (TEL-TEST, Inc) and purified
with QIAGENRNeasy kit and treatedwith DNase (QIAGEN). Reverse transcrip-
tion was carried out using M-MLV (Promega) according to the manufacturer’s
protocol.
Quantitative RT-PCR was carried out using Bio-Rad iTaq SYBR Green
Supermix with ROX according to the manufacturer’s protocol. The amount
of DNA was quantified by DNA Engine Opticon 2 (Bio-Rad). Sequences forCell 137, 99–109, April 3, 2009 ª2009 Elsevier Inc. 107
primers used in RT-PCR are listed in Table S1. Only primers giving specific
PCR products were used. The normalized increase in mRNA level was calcu-
lated according to the following formula: (mRNAV, n/mRNAV, 0)/(mRNAT, n/
mRNAT, o), where mRNAV, n and mRNAV, 0 represent the mRNA level for
a particular VSG at n hr or 0 hr after tbRAP1 RNAi induction, and mRNAT, n
and mRNAT, o represent the mRNA levels for b-tubulin at corresponding time
points.
IF, ChIP, and FACS
IF was carried out as published (Lowell and Cross, 2004). ChIP was carried out
as previously described (Li et al., 2005), with or without the formaldehyde treat-
ment. The precipitated and input DNA samples were loaded onto a nylon
membrane, hybridized with TTAGGG-repeat, tubulin, or Tb11.0330 probes,
and quantified with a phosphorimager. The precipitated amount was calcu-
lated as a percentage of input material. Under both conditions, DNA was soni-
cated to an average size of 300–400 bp. FACSwas carried out as previously (Li
et al., 2005), except the results were analyzed with FlowJo (TreeStar). The cell-
cycle profile was analyzed using the Watson Pragmatic template. Unpaired t
tests were performed in Prism (GraphPad).
ACCESSION NUMBERS
The GenBank accession number for the subcloned full-length tbRAP1
reported in this article is FJ597175.
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